Literature DB >> 6159155

EEG observations in dystrophia myotonica (Curschmann-Steinert).

R S Beijersbergen, A Kemp, W S van Leeuwen.   

Abstract

An investigation has been carried out in a group of 84 (+2) patients suffering from myotonic dystrophia (Curschmann-Steinert). Manual measurements show that in these patients: (1) the alpha rhythms have low frequencies, related to the age of the patient and to the duration and severity of the disease; (2) the alpha rhythms are regular, monotonous; (3) the alpha rhythms have small amplitudes; there appears to be no relation between alpha frequency and amplitude; (4) the alpha indices are high during eyes closed as well as during eyes open. The computer measurements generally appear to concur with the above and in addition show that the bilateral and longitudinal coherences are high, indicating considerable synchrony of the alpha rhythm over large areas on both sides of the head. The possible significance of these observations is discussed.

Entities:  

Mesh:

Year:  1980        PMID: 6159155     DOI: 10.1016/0013-4694(80)90360-0

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  4 in total

1.  Multimodality evoked potentials in myotonic dystrophy.

Authors:  F Sartucci; F Marconi; E Busso; B Rossi; L Murri
Journal:  Ital J Neurol Sci       Date:  1989-02

2.  Short-latency somatosensory evoked potentials in dystrophia myotonica.

Authors:  P R Bartel; B P Lotz; C H Van der Meyden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

3.  "Mitochondrial myopathy" or mitochondrial disease? EEG, ERG, VEP studies in 13 children.

Authors:  A Harden; G Pampiglione; A Battaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-07       Impact factor: 10.154

4.  Intelligence quotient profile in myotonic dystrophy, intergenerational deficit, and correlation with CTG amplification.

Authors:  P Turnpenny; C Clark; K Kelly
Journal:  J Med Genet       Date:  1994-04       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.